BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21410943)

  • 1. A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma.
    Pillay K; McCleod H; Chetty R; Hall P
    World J Surg Oncol; 2011 Mar; 9():31. PubMed ID: 21410943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
    Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
    Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
    Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between postoperative recurrence and expression of cyclin E, p27, and Ki-67 in non-small cell lung cancer without lymph node metastases.
    Takahashi S; Kamata Y; Tamo W; Koyanagi M; Hatanaka R; Yamada Y; Tsushima T; Takaya S; Fukuda I
    Int J Clin Oncol; 2002 Dec; 7(6):349-55. PubMed ID: 12494250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
    Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M
    Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
    Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
    Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
    Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients.
    Reed W; Flørems VA; Holm R; Hannisdal E; Nesland JM
    Virchows Arch; 1999 Aug; 435(2):116-24. PubMed ID: 10599310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up.
    Barbareschi M; van Tinteren H; Mauri FA; Veronese S; Peterse H; Maisonneuve P; Caffo O; Scaioli M; Doglioni C; Galligioni E; Dalla Palma P; Michalides R
    Int J Cancer; 2000 May; 89(3):236-41. PubMed ID: 10861499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
    Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
    Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma.
    Xiangming C; Natsugoe S; Takao S; Hokita S; Tanabe G; Baba M; Kuroshima K; Aikou T
    Cancer; 2000 Sep; 89(6):1214-9. PubMed ID: 11002215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer.
    Kim HK; Park IA; Heo DS; Noh DY; Choe KJ; Bang YJ; Kim NK
    Eur J Surg Oncol; 2001 Aug; 27(5):464-71. PubMed ID: 11504517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features of unexpectedly HER2 positive breast carcinomas: An institutional experience.
    LaBoy C; Siziopikou KP; Rosen L; Blanco LZ; Pincus JL
    Pathol Res Pract; 2021 Jun; 222():153441. PubMed ID: 33857853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression patterns of cell cycle regulators in operable breast cancer.
    Zagouri F; Kotoula V; Kouvatseas G; Sotiropoulou M; Koletsa T; Gavressea T; Valavanis C; Trihia H; Bobos M; Lazaridis G; Koutras A; Pentheroudakis G; Skarlos P; Bafaloukos D; Arnogiannaki N; Chrisafi S; Christodoulou C; Papakostas P; Aravantinos G; Kosmidis P; Karanikiotis C; Zografos G; Papadimitriou C; Fountzilas G
    PLoS One; 2017; 12(8):e0180489. PubMed ID: 28797035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.